It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Cancers occur across species. Understanding what is consistent and varies across species can provide new insights into cancer initiation and evolution, with significant implications for animal welfare and wildlife conservation. We build a pan-species cancer digital pathology atlas (panspecies.ai) and conduct a pan-species study of computational comparative pathology using a supervised convolutional neural network algorithm trained on human samples. The artificial intelligence algorithm achieves high accuracy in measuring immune response through single-cell classification for two transmissible cancers (canine transmissible venereal tumour, 0.94; Tasmanian devil facial tumour disease, 0.88). In 18 other vertebrate species (mammalia = 11, reptilia = 4, aves = 2, and amphibia = 1), accuracy (range 0.57–0.94) is influenced by cell morphological similarity preserved across different taxonomic groups, tumour sites, and variations in the immune compartment. Furthermore, a spatial immune score based on artificial intelligence and spatial statistics is associated with prognosis in canine melanoma and prostate tumours. A metric, named morphospace overlap, is developed to guide veterinary pathologists towards rational deployment of this technology on new samples. This study provides the foundation and guidelines for transferring artificial intelligence technologies to veterinary pathology based on understanding of morphological conservation, which could vastly accelerate developments in veterinary medicine and comparative oncology.
Artificial Intelligence (AI) has the potential of assisting the study and diagnosis of veterinary cancers. Here, the authors build a cancer digital pathology atlas encompassing multiple animal species and demonstrate an AI approach for comparative pathology, which yields insights about immune response and morphological similarities.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details









1 The Institute of Cancer Research, Centre for Evolution and Cancer, London, UK (GRID:grid.18886.3f); The Institute of Cancer Research, Division of Molecular Pathology, London, UK (GRID:grid.18886.3f)
2 University of Cambridge, Madingley Road, Department of Veterinary Medicine, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934)
3 Zoological Society of London, London, UK (GRID:grid.20419.3e) (ISNI:0000 0001 2242 7273); Queen Mary University of London, Charterhouse Sq, Centre for Genomics and Computational Biology, Barts Cancer Institute, London, UK (GRID:grid.4868.2) (ISNI:0000 0001 2171 1133)
4 University of California Santa Barbara, Department of Anthropology, Santa Barbara, USA (GRID:grid.133342.4) (ISNI:0000 0004 1936 9676)
5 University of Utah, Department of Pediatrics and Huntsman Cancer Institute, Salt Lake City, USA (GRID:grid.223827.e) (ISNI:0000 0001 2193 0096); PEEL Therapeutics, Inc., Salt Lake City, USA (GRID:grid.509283.5)
6 University of Turin, Department of Veterinary Sciences, Grugliasco, Italy (GRID:grid.7605.4) (ISNI:0000 0001 2336 6580)
7 The Institute of Cancer Research, Centre for Evolution and Cancer, London, UK (GRID:grid.18886.3f); Queen Mary University of London, Charterhouse Sq, Centre for Genomics and Computational Biology, Barts Cancer Institute, London, UK (GRID:grid.4868.2) (ISNI:0000 0001 2171 1133)
8 Zoological Society of London, London, UK (GRID:grid.20419.3e) (ISNI:0000 0001 2242 7273)
9 Biodesign Institute and School of Life Sciences, Arizona State University, Arizona Cancer Evolution Center, Tempe, USA (GRID:grid.215654.1) (ISNI:0000 0001 2151 2636)
10 The University of Queensland, School of Veterinary Science, Gatton, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537)
11 The Institute of Cancer Research, Centre for Evolution and Cancer, London, UK (GRID:grid.18886.3f); The Institute of Cancer Research, Division of Molecular Pathology, London, UK (GRID:grid.18886.3f); The University of Texas MD Anderson Cancer Center, Department of Translational Molecular Pathology, Houston, USA (GRID:grid.240145.6) (ISNI:0000 0001 2291 4776)